Home › Membranous Glomerulonephritis › Michigan › Ann Arbor
Membranous Glomerulonephritis clinical trials in Ann Arbor, MI
3 studies for Membranous Glomerulonephritis are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Belimumab With Rituximab for Primary Membranous Nephropathy
RecruitingPhase 2
- University of Michigan, Ann Arbor
Nephrotic Syndrome Study Network
RecruitingObservational study
- CS Mott Children's Hospital, University of Michigan, Ann Arbor
- University of Michigan Medical Center, Ann Arbor
Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
RecruitingObservational study
- University of Michigan, Ann Arbor
Membranous Glomerulonephritis trials in other cities
- Durham, NC3 studies
- Philadelphia, PA3 studies
- Spokane, WA3 studies
- Baltimore, MD3 studies
- New York City, NY3 studies
- Cleveland, OH3 studies
Other studies in Ann Arbor
- Prostate Cancer27 studies
- Cancer (all types)26 studies
- Breast Cancer26 studies
- Non-Small Cell Lung Cancer26 studies
- Lung Cancer23 studies
- Colorectal Cancer23 studies
- Heart Failure22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Kidney Cancer (Renal Cell Carcinoma)12 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.